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Abstract
Background: Recently, we have discovered site-specific endonucleases, which recognize and
cleave only DNA sequences with 5-methylcytosine. Two specificities of such endonucleases have
been described. Enzymes BisI, BlsI, and GluI are isoschizomers and hydrolyze the DNA sequence
5'-GCNGC-3'/3'-CGNCG-5', which is methylated in different ways. The enzyme GlaI cleaves the
DNA sequence 5'-GCGC-3'/3'-CGCG-5' if there are two, three or four 5-methylcytosines. The
goal of the present work is to study in detail the composition of recognition sequence and effect
of the methylated cytosines on the efficiency of DNA cleavage by the methyl-directed DNA
endonuclease GlaI
Results: In a recent work we have studied the dependence of GlaI activity on the quantity and
location of 5-methylcytosines in the enzyme recognition sequence 5'-GCGC-3'/3'-CGCG-5'. A
significant DNA cleavage has been observed for oligonucleotide duplexes, which include either
three or four 5-methylcytosines. In this work we have studied dependence of the GlaI activity on
quantity and location of methylated cytosines, as well as on composition of the recognition
sequence.
Conclusion: The list of good substrates for GlaI includes a fully methylated site 5'-CGCG-3'/3'-
GCGC-5', sites with three cytosines of a general structure 5'-PuMGM-3'/3'-PyGMG-5', and one
recognition sequence with two methylated cytosines 5'-AMGT-3'/3'-TGMA-5', where M is 5-
methylcytosine.
GlaI intermediate substrates include sites with three methylated cytosines of a general structure
5'-GMPuM-3'/3'-MGPyG-5', as well as a site with two methylcytosines 5'-GMGT-3'/3'-CGMA-5'.
The site 5'-GMGC-3'/3'-CGMG-5' may be considered a low activity substrate.
Background
Most bacterial site-specific DNA endonucleases are restric-
tion endonucleases. Restriction endonucleases (restric-
tion enzymes) and DNA-methyltransferases (methylases)
of the same specificity form the so-called restriction-mod-
ification (R-M) system. It is supposed that restriction
endonucleases (restriction enzymes) protect the cell
against penetration of foreign DNA (for example phage
DNA), whereas methylases protect the host DNA against
cleavage from their own restriction enzyme. Methylases
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protect DNA by modifying the recognition sequence. Even
the name "restriction endonuclease" originated from
experimentally observed phenomenon – restriction of
bacterial phage propagation in microorganisms [1].
Recently we have discovered site-specific endonucleases,
which exist in bacterial cells without corresponding meth-
ylases and hydrolyze only cytosine-methylated DNA [2-
5]. Based on the current classification [6,7] these enzymes
may be placed into IIM group of site-specific endonucle-
ases, i.e. endonucleases recognizing only methylated
DNA. Three specificities of endonucleases which belong
to the IIM group have been described. The enzyme DpnI
and its isoshizomers recognize the DNA sequence 5'-
G(m6A)TC-3' in which adenine is methylated [8].
Enzymes BisI [2], BlsI [4], and GluI [5] are isoschizomers
and hydrolyze the DNA sequence 5'-GCNGC-3', which is
fully or partially methylated in C5 base position. The
enzyme GlaI recognizes the 5mC-modified sequence 5'-
GCGC-3' [3]. All other known 5mC-specific restriction
enzymes, including McrBC, do not have well defined rec-
ognition sequences and cleavage sites [6]. Thus, GlaI and
another 5mC-specific endonuclease BisI are new proto-
types of site specific DNA endonucleases and their prop-
erties need to be studied in details. Recently we have
shown that the DNA-endonuclease GlaI hydrolyses DNA
sequence 5'-GCGC-3' with varying efficiency, depending
on quantities and positions of C5 methylated cytosines
but does not cleave C4 methylated cytosine sequences [9].
The goal of the present work is to study the effect of the
cytosine methylation and nucleotide sequence of the rec-
ognition site on the efficiency of GlaI DNA cleavage.
Methods
Restriction endonucleases, T4 polynucleotide kinase and
buffer solutions used in this study were provided by
SibEnzyme Ltd. (Russia). Oligodeoxyribonucleotide sub-
Table 1: Structure of oligodeoxyribonucleotides
Name of oligonucleotide Structure of oligonucleotide
G1 5'-CTATGAACGTTTTCGCGCTGACGGACCGTATC-3'
G2 5'-GATACGGTCCGTCAGCGCGAAAACGTTCATAG-3'
G3 5'-CTATGAACGTTTTCGMGCTGACGGACCGTATC-3'
G4 5'-GATACGGTCCGTCAGMGCGAAAACGTTCATAG-3'
G5 5'-CTATGAACGTTTTCGCGMTGACGGACCGTATC-3'
G6 5'-GATACGGTCCGTCAGCGMGAAAACGTTCATAG-3'
G7 5'-CTATGAACGTTTTCGMGMTGACGGACCGTATC-3'
G8 5'-GATACGGTCCGTCAGMGMGAAAACGTTCATAG-3'
G11 5'-CTATGAACGTTTTCAMGMTGACGGACCGTATC-3'
G12 5'-GATACGGTCCGTCAGMGTGAAAACGTTCATAG-3'
G13 5'-CTATGAACGTTTTCGTGMTGACGGACCGTATC-3'
G14 5'-GATACGGTCCGTCAGMAMGAAAACGTTCATAG-3'
G15 5'-CTATGAACGTTTTCAMGTTGACGGACCGTATC-3'
G16 5'-GATACGGTCCGTCAAMGTGAAAACGTTCATAG-3'
G17 5'-CTATGAACGTTTTCAMGCTGACGGACCGTATC-3'
G18 5'-CTATGAACGTTTTCGMGTTGACGGACCGTATC-3'
G19 5'-GATACGGTCCGTCAAMGCGAAAACGTTCATAG-3'
G20 5'-CTATGAACGTTTTCGMAMTGACGGACCGTATC-3'
G21 5'-GATACGGTCCGTCAGTGMGAAAACGTTCATAG-3'
G22 5'-CTATGAACGTTTTCMMGMTGACGGACCGTATC-3'
G23 5'-GATACGGTCCGTCAGMGGGAAAACGTTCATAG-3'
G24 5'-CTATGAACGTTTTCGGGMTGACGGACCGTATC-3'
G25 5'-GATACGGTCCGTCAGMMMGAAAACGTTCATAG-3'
G26 5'-CTATGAACGTTTTCCMGMTGACGGACCGTATC-3'
G27 5'-GATACGGTCCGTCAGMCMGAAAACGTTCATAG-3'
G28 5'-CTATGAACGTTTTCTMGMTGACGGACCGTATC-3'
G29 5'-GATACGGTCCGTCAGMGAGAAAACGTTCATAG-3'
G30 5'-CTATGAACGTTTTCGAGMTGACGGACCGTATC-3'
G31 5'-GATACGGTCCGTCAGMTMGAAAACGTTCATAG-3'
G32 5'-CTATGAACGTTTTCACGMTGACGGACCGTATC-3'
G33 5'-CTATGAACGTTTTCATGMTGACGGACCGTATC-3'
G34 5'-GATACGGTCCGTCAGMATGAAAACGTTCATAG-3'
G35 5'-GATACGGTCCGTCAGCAMGAAAACGTTCATAG-3'
G36 5'-GATACGGTCCGTCAGMACGAAAACGTTCATAG-3'
G37 5'-CTATGAACGTTTTCTMGATGACGGACCGTATC-3'
G38 5'-GATACGGTCCGTCATMGAGAAAACGTTCATAG-3'BMC Molecular Biology 2008, 9:7 http://www.biomedcentral.com/1471-2199/9/7
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strates for endonuclease GlaI were synthesized at SibEn-
zyme Ltd. (Russia). Compositions of the
oligodeoxyribonucleotides are provided in Table 1.
All duplexes were prepared by annealing two complemen-
tary oligodeoxyribonucleotides which differ from each
other in the presence or the absence of methylcytosine
and composition of the nucleotides in the recognition
sequence (underlined in the Table above).
Preparation of a substrate for endonuclease GlaI
The upper strand of each DNA duplex was labeled at the
5'-end with T4 polynucleotide kinase and [32P]ATP. After
purification with Microspin™ G-25 Columns (Amersham
Biosciences UK Limited, England), oligonucleotide was
mixed with complementary unlabeled oligonucleotide in
1:1.5 ratio. The duplex was then annealed by heating to
65°C, followed by slow cooling to room temperature.
Hydrolysis of oligonucleotide duplexes with endonuclease 
GlaI
Hydrolysis reactions were initiated by adding GlaI to 10 μl
of the reaction mixture containing GlaI buffer (Tris-HCl
pH 8.5 (at 25°C), 5 mM MgCl2, 10 mM NaCl, 1.5 mM β-
mercaptoethanol) and oligonucleotide duplex with con-
centration of 62.5 nM. Reactions were carried out at 30°C.
Determination of the product quantities after 
oligonucleotide cleavage
Electrophoresis of the hydrolysis products was carried out
in denaturing 20% PAAG (polyacrylamide gel) with 7 M
urea in tris-borate buffer. Radiolabeled DNA was detected
and quantified by using Personal Molecular Imager (Bio-
Rad laboratories, Inc., USA). For each labeled product, we
determined DLU (Digital Light Units) proportional to the
intensity of [32P] isotope radiation minus the background.
Hydrolysis percentage was determined by dividing the
reaction product DLU by the total DLU, calculated as the
sum of the product DLU and the remaining unhydrolyzed
duplex DLU. Data treatment was performed using the pro-
gram Quantity One – 4.6.2. (Bio-Rad laboratories, Inc.,
USA).
Determination of the enzyme activity
The minimal quantity of the enzyme required to complete
hydrolysis of the oligonucleotide duplex G7*/G8 in GlaI
buffer in 1 hour at the optimal temperature of 30°C was
defined as one unit of enzyme activity.
GlaI activity (in %) for any substrate was determined as a
ratio of tangent in linear range of activities curves for the
studied substrate and an optimal substrate G7*/G8.
Statistical treatment of results
The treatment was performed using the method of a
standard deviation as the statistical test and program Ori-
gin 7.0. Microsoft Office Excel 2003 was used for graphi-
cal representation of the results.
Results and discussion
Recently, we have discovered a new site-specific endonu-
clease GlaI, which does not cleave standard DNA sub-
strates (lambda and T7 DNAs, adenoviral DNA, plasmids
pUC19, pBR322) and which hydrolyzes only the plasmid
DNA containing a gene of DNA-methyltransferase HspAI
[3]. Enzyme M.HspAI methylates the internal cytosine at
position 5 in the sequence 5'-GCGC-3' [3]. This fact
allowed us to propose and then to confirm the hypothesis
that the site-specific endonuclease GlaI cleaves the
sequence 5'-GMGC-3'/3'-CGMG-5' [3]. In a recent work
[9] we have studied the dependence of GlaI activity on the
quantity and location of 5-methylcytosines in the enzyme
recognition sequence. A significant DNA cleavage has
been observed for oligonucleotide duplexes which con-
tain either three or four 5-methylcytosines. A DNA duplex
with four 5-methylcytosines (5'-GMGM-3'/3'-MGMG-5')
displays a maximum level of cleavage efficiency and is
considered to be a canonical substrate. The efficiency
decreases when the quantity of methylated bases is lower.
However, the influence on GlaI activity of the recognition
sequence composition was not clear. In this work we have
studied dependence of the GlaI activity on quantity and
location of methylated cytosines, as well as on composi-
tion of the recognition sequence. Unlike with all other
known restriction endonucleases, it is not possible to pro-
duce a whole set of DNA substrates for GlaI in the form of
plasmid, phage or other native DNA, which have recogni-
tion sites methylated in different ways. In order to study
the properties of endonuclease GlaI, we used chemically
synthesized oligonucleotide duplexes, which include
methylcytosine(s) and nucleotide substitutions in the rec-
ognition sequence 5'-GCGC-3'/3'-CGCG-5'.
Fig. 1 presents the results of the oligonucleotide duplex
G7*/G8 (32P-labeled chain is marked by *) cleavage by
different endonucleases. This duplex contains the com-
pletely methylated recognition sequence 5'-GMGM-3'/3'-
MGMG-5'. Fig. 1 shows that duplex G7*/G8 is hydrolyzed
by restriction endonucleases Rsr2I and AclI (recognition
sites 5'-CGG^WCCG-3' and 5'-AAC^GTT-3' (respectively)
as well as with enzyme GlaI.
As Figure 1 shows, duplex G8*/G7 is hydrolyzed with GlaI
even more efficient than with restriction endonucleases
Rsr2I and AclI.
In order to study dependence of GlaI activity on the quan-
tity and location of modified cytosines in the recognitionBMC Molecular Biology 2008, 9:7 http://www.biomedcentral.com/1471-2199/9/7
Page 4 of 12
(page number not for citation purposes)
sequence, we analyzed the hydrolysis efficiency of various
methylated oligonucleotides.
Experimental data have been processed as indicated in
"Methods" and dependence of the hydrolyzed product
(expressed in percent) on the time of the incubation are
presented in Figures 2, 3, 4. The lines shown in these fig-
ures represent a typical Michaelis-Menten kinetics
As Figure 2 shows, the highest enzyme activity is observed
for a fully methylated duplex G7*/G8 with four 5-methyl-
cytosines. Recognition sequences with three methylated
cytosines are hydrolyzed less effectively. There are two
groups of these substrates: oligonucleotides with two
internal 5-methylcytosines 5'-PuMGM-3'/3'PyGMG-5'
and oligonucleotides with one internal 5-methylcytosine
5'-GMPuM-3'/3'-MGPyG. GlaI activity in hydrolysis of all
other possible recognition sequences with three 5-methyl-
cytosines is less than 1% of G7*/G8 cleavage rate. Fig. 2
shows that GlaI activity is about 60% for cleavage of both
strands of duplex 5'-AMGM-3'/3'TGMG-5', 36%–41% for
the upper strand and 27%–31% for a bottom strand of
duplex 5'-GMGM-3'/3'CGMG-5'. Cleavage efficiency of
the oligonucleotides with two external 5-methylcytosines
is 16–17% for both strands, except for the strand contain-
ing 5'-GTGM-3' as this strand is cleaved with 21%–25% of
the G7*/G8 efficiency (Fig. 3).
Some recognition sequences with two methylated
cytosines are also substrates for GlaI. The general structure
of these substrates is 5'-PuMGPy-3'/3'PyGMPu-5'. GlaI
activity in hydrolysis of all other possible recognition
sequences with two 5-methylcytosines is less than 1% of
G7*/G8 cleavage rate. Fig. 4 shows that GlaI activity is 23–
26% for cleavage of both strands of duplex 5'-AMGT-3'/3'-
TGMA-5' and 13% for cleavage of both strand of duplex
5'-GMGT-3'/3'-CGMA-5'. There is an exception for a
strand, which contains sequence 5'-GMGT-3', followed by
purine nucleotides. This strand is hydrolyzed two times
faster than the complementary chain. Finally, we have
observed approximately 6% enzyme activity in hydrolysis
of the sequence 5'-GMGC-3'/3'-CGMG-5' when com-
pared to GlaI activity with G7*/G8 substrate.
The experimental results for all oligonucleotide duplexes
are presented in Table 2. GlaI displays a maximal activity
in hydrolysis of the fully methylated sequence 5'-GCGC-
3'/3'-CGCG-5'. We determine the enzyme's activity in
hydrolysis of other DNA duplexes as a percent of this oli-
gonucleotide cleavage activity. The table shows that GlaI
effectively cleaves DNA sequence 5'-GCGC-3'/3'-CGCG-5'
containing 3 modified bases, when both internal
cytosines are methylated. Sites with two external and one
internal cytosine, as well as with two internal modified
cytosines, are cleaved less efficiently. Oligonucleotide
with two modified bases on one chain is cleaved insignif-
icantly and only at larger concentrations of the enzyme.
Oligonucleotide duplexes, which carry two methylcy-
tosines in one chain (5'-GMGM-3'/3'-CGCG-5'), are
cleaved by GlaI at enzyme concentrations more than 100
units per microlitre [9]. According to Table 2, GlaI activity
less than 1% is observed for duplexes with two external 5-
mehylcytosines (5'-GPyGM-3'/3'-MPuCG-5'), or one
external and one internal 5-mehylcytosines in different
chains (5'-PuPyGM-3'/3'-PyPuMG-5' and 5'-GMPuPy-3'/
3'-MGPyPu-5'). We do not detect GlaI hydrolysis of oligo-
nucleotides when purines are replaced by pyrimidines in
Cleavage of the oligonucleotide duplex G7*/G8 by endonu- cleases Figure 1
Cleavage of the oligonucleotide duplex G7*/G8 by endonu-
cleases. Runs: 1 – DNA duplex without the enzyme; 2 – 
hydrolysis with restriction endonuclease Rsr2I; 3 – hydrolysis 
with restriction endonuclease AclI; 4, 5 – hydrolysis with 
endonuclease GlaI (30 units and 100 units, respectively).BMC Molecular Biology 2008, 9:7 http://www.biomedcentral.com/1471-2199/9/7
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the recognition sequence (5'-PyMGM-3'/3'-PuGMG-5', 5'-
GMGPu-3'/3'-MGMPy-5', 5'-GPuGM-3'/3'-MPyMG-5', 5'-
GMPyM-3'/3'-MGPuG-5' and 5'-PyMGPu-3'/3'-PuGMPy-
5').
In Fig. 5 we have summarized the data obtained in this
study. Tested substrates have been divided into several
groups (blue, green and red colour). GlaI cleaves DNA
substrates with the following recognition sequences:
a. 5'-GMGM-3'/3'-MGMG-5' (four 5-methylcytosines, red
colour);
b. 5'-PuMGM-3'/3'PyGMG-5' (three 5-methylcytosines,
green colour);
c. 5'-GMPuM-3'/3'-MGPyG-5' (three 5-methylcytosines,
green colour);
d. 5'-PuMGPy-3'/3'PyGMPu-5' (two 5-methylcytosines,
blue colour).
A fully methylated sequence 5'-GCGC-3'/3'-CGCG-5' is
the best substrate, which we consider as a canonical one.
The above listed substrates with three methylcytosines are
divided into two subgroups (b and c). The first subgroup
includes good substrates with two internal cytosines of
general structure 5'-PuMGM-3'/3'PyGMG-5' and the sec-
ond subgroup includes intermediate substrates with two
external 5-methylcytosines of general structure 5'-
GMPuM-3'/3'-MGPyG-5'. Cleavage activity of GlaI in the
first subgroup varies from 25% up to 66% of that for the
site with four 5-methylcytosines (a), whereas the second
subgroup cleavage activity is between 10% and 20%. Var-
iation of GlaI activity in cleavage of recognition sequences
with two internal 5-methylcytosines (subgroup d) is 5% –
26%.
In our analysis of data in Figure 5, we should note the fol-
lowing peculiarities of GlaI activity.
A. For some sites there is a difference in cleavage efficiency
of two strands of recognition sequence. This is occurs for
Dependence of the hydrolyzed product (in %) (axis Y) on the time of reaction Figure 2
Dependence of the hydrolyzed product (in %) (axis Y) on the time of reaction: G7*/G8 (5'-TTTTCGMGMTGACG-3'/3'-
AAAAGMGMGACTGC-5') – n, G8*/G7 (5'-CGTCAGMGMGAAAA-3'/3'-GCAGTMGMGCTTTT-5') – &#x25A1;, G3*/G8 
(5'-TTTTCGMGCTGACG-3'/3'-AAAAGMGMGACTGC-5') – &#x25BD;, G8*/G3 (5'-CGTCAGMGMGAAAA-3'/3'-
GCAGTCGMGCTTTT-5') – t, G4*/G7 (5'-CGTCAGMGCGAAAA-3'/3'-GCAGTMGMGCTTTT-5') – &#x25B3;, G7*/G4 
(5'-TTTTCGMGMTGACG-3'/3'-AAAAGCGMGACTGC-5') – s, G11*/G12 (5'-TTTTCAMGMTGACG-3'/3'-AAAAGT-
GMGACTGC-5') – l, G12*/G11 (5'-CGTCAGMGTGAAAA-3'/3'-GCAGTMGMACTTTT-5') – m, G7*/G6 (5'-TTTTCGM-
GMTGACG-3'/3'-AAAAGMGCGACTGC-5') –  .
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Dependence of the hydrolyzed product (in %) (axis Y) on the time of reaction Figure 3
Dependence of the hydrolyzed product (in %) (axis Y) on the time of reaction: a) G7*/G6 (5'-TTTTCGMGMTGACG-3'/3'-
AAAAGMGCGACTGC-5') – n, G6*/G7 (5'-CGTCAGCGMGAAAA-3'/3'-GCAGTMGMGCTTTT-5') – &#x25A1;, G5*/G8 
(5'-TTTTCGCGMTGACG-3'/3'-AAAAGMGMGACTGC-5') – l, G8*/G5 (5'-CGTCAGMGMGAAAA-3'/3'-GCAGTM-
GCGCTTTT-5') – m, G13*/G14 (5'-TTTTCGTGMTGACG-3'/3'-AAAAGMAMGACTGC-5') – s, G14*/G13 (5'-CGT-
CAGMAMGAAAA-3'/3'-GCAGTMGTGCTTTT-5') – &#x25B3;, G4*/G7 (5'-CGTCAGMGCGAAAA-3'/3'-
GCAGTMGMGCTTTT-5') –  ; b) G13*/G14 (5'-TTTTCGTGMTGACG-3'/3'-AAAAGMAMGACTGC-5') – s, G14*/G13 
(5'-CGTCAGMAMGAAAA-3'/3'-GCAGTMGTGCTTTT-5') – &#x25B3;, G20*/G21 (5'-TTTTCGMAMTGACG-3'/3'-
AAAAGMGTGACTGC-5') – t, G21*/G20 (5'-CGTCAGTGMGAAAA-3'/3'-GCAGTMAMGCTTTT-5') – &#x25BD;.
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Dependence of the hydrolyzed product (in %) (axis Y) on the time of reaction Figure 4
Dependence of the hydrolyzed product (in %) (axis Y) on the time of reaction: a) G3*/G4 (5'-TTTTCGMGCTGACG-3'/3'-
AAAAGCGMGACTGC-5') – n, G4*/G3 (5'-CGTCAGMGCGAAAA-3'/3'-GCAGTCGMGCTTTT-5') – &#x25A1;, G15*/
G16 (5'-TTTTCAMGTTGACG-3'/3'-AAAAGTGMAACTGC-5') – l, G16*/G15 (5'-CGTCAAMGTGAAAA-3'/3'-
GCAGTTGMACTTTT-5') – m, G18*/G19 (5'-TTTTCGMGTTGACG-3'/3'-AAAAGCGMAACTGC-5') – s, G19*/G18 (5'-
CGTCAAMGCGAAAA-3'/3'-GCAGTTGMGCTTTT-5') – &#x25B3;, G7*/G6 (5'-TTTTCGMGMTGACG-3'/3'-AAAAGM-
GCGACTGC-5') –  ; b) G12*/G17 (5'-CGTCAGMGTGAAAA-3'/3'-GCAGTCGMACTTTT-5') – t, G17*/G12 (5'-TTT-
TCAMGCTGACG-3'/3'-AAAAGTGMGACTGC-5') – &#x25BD;, G18*/G19 (5'-TTTTCGMGTTGACG-3'/3'-
AAAAGCGMAACTGC-5') – s, G19*/G18 (5'-CGTCAAMGCGAAAA-3'/3'-GCAGTTGMGCTTTT-5') – &#x25B3;.
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Table 2: GlaI activity on methylated oligonucleotide duplexes
Oligonucleotide duplex The central part of structure of a duplex Relative enzyme's activity (%) and standard 
error
G7*/G8 5'-TTTTCGMGMTGACG-3' 100 ± 5
3'-AAAAGMGMGACTGC-5'
G8*/G7 5'-CGTCAGMGMGAAAA-3' 97 ± 5
3'-GCAGTMGMGCTTTT-5'
G3*/G8 5'-TTTTCGMGCTGACG-3' 28 ± 2
3'-AAAAGMGMGACTGC-5'
G8*/G3 5'-CGTCAGMGMGAAAA-3' 40 ± 2
3'-GCAGTCGMGCTTTT-5'
G4*/G7 5'-CGTCAGMGCGAAAA-3' 31 ± 2
3'-GCAGTMGMGCTTTT-5'
G7*/G4 5'-TTTTCGMGMTGACG-3' 36 ± 2
3'-AAAAGCGMGACTGC-5'
G11*/G12 5'-TTTTCAMGMTGACG-3' 61 ± 3
3'-AAAAGTGMGACTGC-5'
G12*/G11 5'-CGTCAGMGTGAAAA-3' 60 ± 3
3'-GCAGTMGMACTTTT-5'
G6*/G7 5'-CGTCAGCGMGAAAA-3' 16 ± 1
3'-GCAGTMGMGCTTTT-5'
G7*/G6 5'-TTTTCGMGMTGACG-3' 17 ± 1
3'-AAAAGMGCGACTGC-5'
G5*/G8 5'-TTTTCGCGMTGACG-3' 17 ± 1
3'-AAAAGMGMGACTGC-5'
G8*/G5 5'-CGTCAGMGMGAAAA-3' 17 ± 1
3'-GCAGTMGCGCTTTT-5'
G13*/G14 5'-TTTTCGTGMTGACG-3' 21 ± 1
3'-AAAAGMAMGACTGC-5'
G14*/G13 5'-CGTCAGMAMGAAAA-3' 16 ± 1
3'-GCAGTMGTGCTTTT-5'
G20*/G21 5'-TTTTCGMAMTGACG-3' 17 ± 1
3'-AAAAGMGTGACTGC-5'
G21*/G20 5'-CGTCAGTGMGAAAA-3' 25 ± 1
3'-GCAGTMAMGCTTTT-5'
G3*/G4 5'-TTTTCGMGCTGACG-3' 5 ± 1
3'-AAAAGCGMGACTGC-5'
G4*/G3 5'-CGTCAGMGCGAAAA-3' 6 ± 1
3'-GCAGTCGMGCTTTT-5'
G12*/G17 5'-CGTCAGMGTGAAAA-3' 28 ± 1
3'-GCAGTCGMACTTTT-5'
G17*/G12 5'-TTTTCAMGCTGACG-3' 13 ± 1
3'-AAAAGTGMGACTGC-5'
G15*/G16 5'-TTTTCAMGTTGACG-3' 26 ± 1
3'-AAAAGTGMAACTGC-5'
G16*/G15 5'-CGTCAAMGTGAAAA-3' 23 ± 1
3'-GCAGTTGMACTTTT-5'
G18*/G19 5'-TTTTCGMGTTGACG-3' 12 ± 1
3'-AAAAGCGMAACTGC-5'
G19*/G18 5'-CGTCAAMGCGAAAA-3' 14 ± 1
3'-GCAGTTGMGCTTTT-5'
G7*/G2 5'-TTTTCGMGMTGACG-3' < 1
3'-AAAAGCGCGACTGC-5'
G2*/G7 5'-CGTCAGCGCGAAAA-3' < 1
3'-GCAGTMGMGCTTTT-5'
G13*/G35 5'-TTTTCGTGMTGACG-3' < 1
3'-AAAAGMACGACTGC-5'
G35*/G13 5'-CGTCAGCAMGAAAA-3' < 1
3'-GCAGTMGTGCTTTT-5'
G5*/G6 5'-TTTTCGCGMTGACG-3' < 1
3'-AAAAGMGCGACTGC-5'
G6*/G5 5'-CGTCAGCGMGAAAA-3' < 1BMC Molecular Biology 2008, 9:7 http://www.biomedcentral.com/1471-2199/9/7
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site 5'-GMGM-3'/3'-CGMG-5', but not for 5'-AMGM-3'/3'-
TGMG-5'; and also occurs for site 5'-GTGM-3'/3'-MAMG-
5'. There is no significant difference in GlaI cleavage activ-
ity of two strands for other sites.
B. We observe that the nucleotides which surround the 4
base recognition sequence can influence the enzyme's
cleavage activity for sites 5'-GTGM-3'/3'-MAMG-5' and 5'-
GMGT-3'/3'-CGMA-5'. GlaI displays elevated levels of
activity, about 26%, in the upper strand cleavage of those
recognition sequences which are given in bold in Figure 5.
The upper strand's recognition sequence is either 5'-
GMGT-3' or 5'-GTGM-3', followed by a block of purine
nucleotides. It can be concluded that GlaI displays higher
activity in cleavage of one chain of the recognition
sequence if this strand contains 5-methylcytosine, T and
two G bases, followed by A and G sequence.
C. For DNA cleavage, nucleotide A is a better base than G
in the purine position of recognition sequences 5'-
3'-GCAGTMGCGCTTTT-5'
G12*/G32 5'-CGTCAGMGTGAAAA-3' < 1
3'-GCAGTMGCACTTTT-5'
G32*/G12 5'-TTTTCACGMTGACG-3' < 1
3'-AAAAGTGMGACTGC-5'
G33*/G34 5'-TTTTCATGMTGACG-3' < 1
3'-AAAAGTAMGACTGC-5'
G34*/G3 5'-CGTCAGMATGAAAA-3' < 1
3'-GCAGTMGTACTTTT-5'
G13*/36 5'-TTTTCGTGMTGACG-3' < 1
3'-AAAAGCAMGACTGC-5'
G36*/13 5'-CGTCAGMACGAAAA-3' < 1
3'-GCAGTMGTGCTTTT-5'
G3*/G6 5'-TTTTCGMGCTGACG-3' < 1
3'-AAAAGMGCGACTGC-5'
G6*/G3 5'-CGTCAGCGMGAAAA-3' < 1
3'-GCAGTCGMGCTTTT-5'
G4*/G5 5'-CGTCAGMGCGAAAA-3' < 1
3'-GCAGTMGCGCTTTT-5'
G5*/G4 5'-TTTTCGCGMTGACG-3' < 1
3'-AAAAGCGMGACTGC-5'
G22*/G23 5'-TTTTCMMGMTGACG-3' < 1
3'-AAAAGGGMGACTGC-5'
G23*/G22 5'-CGTCAGMGGGAAAA-3' < 1
3'-GCAGTMGMMCTTTT-5'
G24*/G25 5'-TTTTCGGGMTGACG-3' < 1
3'-AAAAGMMMGACTGC-5'
G25*/G24 5'-CGTCAGMMMGAAAA-3' < 1
3'-GCAGTMGGGCTTTT-5'
G28*/G29 5'-TTTTCTMGMTGACG-3' < 1
3'-AAAAGAGMGACTGC-5'
G29*/G28 5'-CGTCAGMGAGAAAA-3' < 1
3'-GCAGTMGMTCTTTT-5'
G30*/G31 5'-TTTTCGAGMTGACG-3' < 1
3'-AAAAGMTMGACTGC-5'
G31*/G30 5'-CGTCAGMTMGAAAA-3' < 1
3'-GCAGTMGAGCTTTT-5'
G37*/G38 5'-TTTTCTMGATGACG-3' < 1
3'-AAAAGAGMTACTGC-5'
G38*/G37 5'-CGTCATMGAGAAAA-3' < 1
3'-GCAGTAGMTCTTTT-5'
G26*/G23 5'-TTTTCCMGMTGACG-3' < 1
3'-AAAAGGGMGACTGC-5'
G23*/G26 5'-CGTCAGMGGGAAAA-3' < 1
3'-GCAGTMGMCCTTTT-5'
G27*/G24 5'-CGTCAGMCMGAAAA-3' < 1
3'-GCAGTMGGGCTTTT-5'
G24*/G27 5'-TTTTCGGGMTGACG-3' < 1
3'-AAAAGMCMGACTGC-5'
Table 2: GlaI activity on methylated oligonucleotide duplexes (Continued)BMC Molecular Biology 2008, 9:7 http://www.biomedcentral.com/1471-2199/9/7
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PuMGM-3'/3'PyGMG-5' and 5'-PuMGPy-3'/3'PyGMPu-
5'. There is no difference in activity for either nucleotide A
or G in the site 5'-GMPuM-3'/3'-MGPyG-5'. The greatest
activity variance, of more than 4-fold, occurs in the cleav-
age of oligonucleotides with two internal 5-methylcy-
tosines. Surprisingly, one of them, 5'-AMGT-3'/3'-TGMA-
5', is a good substrate for cleavage with enzyme GlaI
(about 25% activity), whereas the other, 5'-GMGC-3'/3'-
CGMG-5', displays cleavage activity approximately 6%.
D. The symmetrical palindromic site 5'-AMGT-3'/3'-
TGMA-5' is a better substrate than those with three meth-
ylated cytosines, with two of these cytosines being exter-
nal. We consider this site to be a good substrate of GlaI.
Results presented in Table 2 and Fig. 5 are further devel-
opment of the enzyme GlaI characterization we began ear-
lier [3,9]. In this study we have made some corrections in
cleavage efficiency estimation for intermediate and low
activity methylated substrates which have the general
structure 5'-GCGC-3'/3'-CGCG-5'. We have also tested all
possible 4-nucleotide DNA substrates. In the future we are
planning to study in detail the influence of nucleotides
which surround this site on the enzyme GlaI activity.
Conclusion
Thus, the list of good substrates for GlaI includes a fully
methylated site 5-CGCG-3'/3'-GCGC-5' (a canonical site,
100% cleavage activity), sites with three cytosines of a
general structure 5'-PuMGM-3'/3'PyGMG-5' (27–61%)
and one recognition sequence with two methylated
cytosines 5'-AMGT-3'/3'-TGMA-5' (26%). GlaI intermedi-
ate substrates display activity which is 10–20% of the
canonical one, and include sites with three methylated
cytosines of a general structure 5'-GMPuM-3'/3'-MGPyG-
5' as well as a site with two methylcytosines 5'-GMGT-3'/
GlaI activity on methylated oligonucleotide duplexes Figure 5
GlaI activity on methylated oligonucleotide duplexes.
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3'-CGMA-5'. The site 5'-GMGC-3'/3'-CGMG-5' displays
about 6% activity and may be considered a low activity
substrate. Although in some cases one strand of the inter-
mediate substrates is cleaved with more than 20% activity,
the total activity in duplex cleavage is less than 20% due
to low cleavage activity of the second strand.
The role of GlaI, and similar IIM type enzymes, in a bacte-
rial cell remains unclear. One possible function of these
enzymes is protection against the invasion by foreign
methylated phage DNA [2,3]. It is well known that in
some phage DNAs there is a 5-methylcytosine in the
nucleotide sequence 5'-GMGC-3'. This site is a substrate
for methyl-directed DNA endonuclease GlaI [6]. How-
ever, according to the data of the current study, GlaI dis-
plays minimal activity in cleavage of recognition sequence
5'-GMGC-3'/3'-CGMG-5' and perhaps, this methyl-
directed DNA endonuclease has some other function(s)
in a bacterial cell.
GlaI may find a practical application in determination of
DNA methylation status of eukaryotic and human
genomes. Mammalian genomes contain the methylated
dinucleotide 5'-CG-3' and study of this CG methylation in
chromosomal DNA is in progress in many scientific insti-
tutions [10].
A present work has shown that GlaI recognizes a whole set
of short 5mC-methylated nucleotide sequences. The list of
good GlaI substrates includes recognition sequences with
one methylated CG dinucleotide 5'-AMGT-3'/3'-TGMA-5'.
Recognition sequences of other good substrates (5'-
GMGM-3'/3'-MGMG-5' with four 5-methylcytosines and
5'-PuMGM-3'/3'PyGMG-5' with three 5-methylcytosines)
include at least one methylated CG dinucleotide and may
overlap with another 5mCG dinucleotide forming DNA
sequence 5'-MGMG-3'. A general structure of such GlaI
and two methylated CG dinucleotides overlapping sites is
5'-(A/G)CGCG-3', where the underlined sequence is the
GlaI recognition site. Most GlaI intermediate activity sub-
strates include either one methylated CG dinucleotide (5'-
GMGT-3'/3'-CGMA-5') or may overlap with tetranucle-
otide 5'-MGMG-3' as well. Finally, GlaI low activity sub-
strate 5'-GMGC-3'/3-CGMG-5' also contains methylated
CG dinucleotide.
So, GlaI cleaves all these methylated DNA sequences and
this enzyme may be used for analyzing methylation of
specific CpG sites [11,12].
PCR-amplification of the genomic region of the interest
will be more sensitive after pretreatment of DNA sample
with GlaI endonuclease. Only the initially non-methyl-
ated and thus non-hydrolyzed fragment of DNA will be
amplified. A detailed description of GlaI application will
be provided in our forthcoming papers.
Authors' contributions
TNN purified the enzyme. GVT carried out the experi-
ments on oligonucleotides cleavage, SKD coordinated the
project and prepared the final manuscript. All authors
have read and approved the final manuscript.
Acknowledgements
We thank Dr. Ray Williams for critical reading and language revision of the 
manuscript.
References
1. Arber W, Linn S: DNA modification and restriction.  Annual
Review of Biochemistry 1969, 38:467-500.
2. Chmuzh EV, Kashirina Yu G, Tomilova Yu E, Mezentseva NV, Dedkov
VS, Gonchar DA, Abdurashitov MA, Degtyarev SKh: New endonu-
clease restriction BisI from Bacillus subtilis T30 recognizes
methylated sequence DNA 5'-G(5mC)N^GC-3'.   [http://sci
ence.sibenzyme.com/article8_article_7_1.phtml].
3. Chernukhin VA, Nayakshina TN, Abdurashitov MA, Tomilova Yu E,
Mezentseva NV, Dedkov VS, Mikhnenkova NA, Gonchar DA, Degt-
yarev SKh: New restriction endonuclease GlaI recognizes
methylatedsequence5'-G(5mC)G^C-3'.   [http://science.siben
zyme.com/article8_article_11_1.phtml].
4. Chernukhin VA, Tomilova Yu E, Chmuzh EV, Sokolova OO, Dedkov
VS, Degtyarev SKh: Site-specific endonuclease BlsI recognizes
DNA sequence 5'-G(5mC)NG^C-3' and cleaves it
producing3'stickyends.   [http://science.sibenzyme.com/
article8_article_25_1.phtml].
5. Chernukhin VA, Chmuzh EV, Tomilova Yu E, Nayakshina TN, Gon-
char DA, Dedkov VS, Degtyarev SKh: A novel site-specific endo-
nuclease GluI recognizes methylated DNA sequence 5'-
G(5mC)N^G(5mC)-3'/3'-(5mC)GN^(5mC)G.   [ h t t p : / / s c i
ence.sibenzyme.com/article8_article_24_1.phtml].
6. Roberts RJ, Belfort M, Bestor T, Bhagwat AS, Bickle TA, Bitinaite J,
Blumenthal RM, Degtyarev SKh, Dryden DTF, Dybvig K, Firman K,
Gromova ES, Gumport RI, Halford SE, Hattman S, Heitman J, Hornby
DP, Janulaitis A, Jeltsch A, Josephsen J, Kiss A, Klaenhammer TR,
Kobayashi I, Kong H, Krûger DH, Lacks S, Marinus MG, Miyahara M,
Morgan RD, Murray NE, Nagaraja V, Piekarowicz A, Pingoud A,
Raleigh E, Rao DN, Reich N, Repin VE, Selker EU, Shaw PC, Stein DC,
Stoddard BL, Szybalski W, Trautner TA, Van Etten JL, Vitor JMB, Wil-
son GG, Xu SY: A nomenclature for restriction enzymes,
DNA methyltransferases, homing endonucleases and their
genes.  Nucleic Acid Res 2003, 31:1805-1812.
7. Pingoud A, Jeltsch A: Structure and function of type II restric-
tion endonucleases.  Nucleic Acids Research 2001, 29:3705-3727.
8. Lac S, Greenberg B: A deoxyribonuclease of Diplococcus pneu-
moniae specific for methylated DNA.  J Biol Chem 1975,
250:4060-4066.
9. Tomilova JE, Chernukhin VA, Degtyarev SKh: Dependence of site-
specific endonuclease GlaI activity on quantity and location
of methylcytosines in the recognition sequence 5'-GCGC-3'.
[http://science.sibenzyme.com/article10_article_22_1.phtml].
10. Eckhardt F, Beck S, Gut IG, Berlin K: Future potential of the
Human Epigenome Project.  Expert Rev Mol Diagn 2004,
4:609-618.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Molecular Biology 2008, 9:7 http://www.biomedcentral.com/1471-2199/9/7
Page 12 of 12
(page number not for citation purposes)
11. Bird A, Southern EM: Use of restriction enzymes to study
eukaryotic DNA methylation: I. The methylation pattern in
ribosomal DNA from Xenopus laevis.  J Mol Biol 1978,
118:27-47.
12. Takamiya T, Hosobuchi S, Asai K, Nakamura E, Tomioka K, Kawase
M, Kakutani T, Patersonet AH, Murakami Ya, Okuizumi H: Restic-
tion landmark genome scanning method using isoshizomers
(MspI/HpaII) for DNA methylation analysis.  Electrophoresis
2006, 27:2846-2856.
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral